{
    "2021-11-19": [
        [
            {
                "time": "2023-10-17",
                "original_text": "EQT, BioNTech investor consider bid for Novartis arm Sandoz -report",
                "features": {
                    "keywords": [
                        "EQT",
                        "BioNTech",
                        "investor",
                        "bid",
                        "Novartis",
                        "Sandoz"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-17",
                "original_text": "UPDATE 2-EQT, BioNTech investor consider bid for Novartis arm Sandoz -report",
                "features": {
                    "keywords": [
                        "EQT",
                        "BioNTech",
                        "investor",
                        "bid",
                        "Novartis",
                        "Sandoz"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}